153 related articles for article (PubMed ID: 37195975)
21. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).
Goldkuhle M; Dimaki M; Gartlehner G; Monsef I; Dahm P; Glossmann JP; Engert A; von Tresckow B; Skoetz N
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012556. PubMed ID: 30001476
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
Ann Oncol; 2007 Feb; 18(2):288-92. PubMed ID: 17088328
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
[TBL] [Abstract][Full Text] [Related]
25. Advanced age is not the decisive factor in chemotherapy of small cell lung cancer: a population-based study.
Rao H; Zhou S; Mei A; Yao A; Xie S
Aging (Albany NY); 2022 Jun; 14(11):4827-4838. PubMed ID: 35680571
[TBL] [Abstract][Full Text] [Related]
26. Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.
Veit-Rubin N; Rapiti E; Usel M; Benhamou S; Vinh-Hung V; Vlastos G; Bouchardy C
Oncologist; 2012; 17(6):783-91. PubMed ID: 22588325
[TBL] [Abstract][Full Text] [Related]
27. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
28. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
29. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
[TBL] [Abstract][Full Text] [Related]
30. Survival after subsequent non-Hodgkin's lymphoma and non-small cell lung cancer in patients with malignant thymoma.
Parzen JS; Bates JE; Milano MT; Dhakal S
J Thorac Dis; 2016 Dec; 8(12):3605-3613. PubMed ID: 28149555
[TBL] [Abstract][Full Text] [Related]
31. Expression of placental growth factor gene in lung cancer.
Woo IS; Park MJ; Byun JH; Hong YS; Lee KS; Park YS; Lee JA; Park YI; Ahn HK
Tumour Biol; 2004; 25(1-2):1-6. PubMed ID: 15192305
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
Han J; Fu C; Li B
Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
[TBL] [Abstract][Full Text] [Related]
33. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
[TBL] [Abstract][Full Text] [Related]
34. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer.
Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M
Thorac Cancer; 2020 Jun; 11(6):1578-1586. PubMed ID: 32286017
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group.
Engert A; Ballova V; Haverkamp H; Pfistner B; Josting A; Dühmke E; Müller-Hermelink K; Diehl V;
J Clin Oncol; 2005 Aug; 23(22):5052-60. PubMed ID: 15955904
[TBL] [Abstract][Full Text] [Related]
36. Role of local treatment in primary breast B-cell non-Hodgkin's lymphoma: a propensity score matching-based analysis from SEER database.
Zhang M; Liu N; Wang BY; Zhang J; Zhao A; Yang J; Yang J
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):22-31. PubMed ID: 35049015
[TBL] [Abstract][Full Text] [Related]
37. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
LeMieux MH; Solanki AA; Mahmood U; Chmura SJ; Koshy M
Cancer Med; 2015 Apr; 4(4):513-8. PubMed ID: 25620577
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of Clinical Characteristics and Prognostic Factors of 223 Newly Diagnosed Hodgkin's Lymphoma Patients].
Liu S; Ma J; Yue YF; Li Q; Yang HL; Yu Y; Wang XF; Zhao ZG; Zhang YZ; Wang YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1296-300. PubMed ID: 26524026
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients].
Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621
[TBL] [Abstract][Full Text] [Related]
40. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
